Effect of Acupressure Applied Before Cystectomy on Preoperative Anxiety Level
NCT ID: NCT05325307
Last Updated: 2025-11-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
60 participants
INTERVENTIONAL
2022-10-01
2024-12-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effect of Acupressure on Procedural Pain, Anxiety and Hemodynamic Variables During Chest Tube Removal
NCT05875337
The Effect of Post-Cesarean Section Acupressure on the Severity of Pain and First Mobilization Distance
NCT05311449
The Effect of Acupressure on Preoperative Anxiety and Postoperative Pain and Nausea-Vomiting
NCT06040411
The Effects of Acupressure on Pain After Cesarean Section
NCT04337801
Effects of Acupressure Applied Before Cesarean Delivery on Anxiety, Physiological Parameters and Fetal Heart Rate
NCT06953037
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Acupressure Group (experimental)
The experimental group will be given acupressure.
Acupressure
The experimental group will start with HT7 points and continue LI4 and EX-NH3 points. The application will be carried out by determining the priority order of the points with the draw. Attention will be paid to the intensity and duration of the pressure deemed appropriate. Since the individuals' responses will differ, the stiffness and pressure will be adjusted according to the individual's sensitivity not to cause tissue damage. Before starting the application, around the area to be pressed for 20-30 seconds will be gently rubbed with palm. With the gentle rubbing of the surrounding tissue, the tension and tissue sensitivity in warming, relaxing and preparatory will be reduced, and the tissue will be relieved. After, the point determined will be pressed manually for 2 minutes.
Placebo Acupressure Group (control)
The placebo group will be given placebo acupressure
Placebo acupressure
In the placebo acupressure group , the points 1.5 cm away from the HT7, LI4, and EX-NH3 points will be applied for an average of 15 minutes. Less pressure will be applied.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Acupressure
The experimental group will start with HT7 points and continue LI4 and EX-NH3 points. The application will be carried out by determining the priority order of the points with the draw. Attention will be paid to the intensity and duration of the pressure deemed appropriate. Since the individuals' responses will differ, the stiffness and pressure will be adjusted according to the individual's sensitivity not to cause tissue damage. Before starting the application, around the area to be pressed for 20-30 seconds will be gently rubbed with palm. With the gentle rubbing of the surrounding tissue, the tension and tissue sensitivity in warming, relaxing and preparatory will be reduced, and the tissue will be relieved. After, the point determined will be pressed manually for 2 minutes.
Placebo acupressure
In the placebo acupressure group , the points 1.5 cm away from the HT7, LI4, and EX-NH3 points will be applied for an average of 15 minutes. Less pressure will be applied.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Conscious and cooperative
* Speaks and understands Turkish,
* 18-65 years old,
* Before surgery,
* Stable general condition,
* No sensitivity in the area where acupressure/placebo acupressure will be applied,
* 15 July 2022 - 15 July 2023 hospitalized in the urology clinic,
* No active COVID-19 infection,
* Patients without any psychiatric diagnosis will be included.
Exclusion Criteria
* Conscious and uncooperative,
* Not speaking or understanding Turkish,
* Not between the ages of 18-65,
* No surgical intervention planned,
* The planned emergency surgical intervention,
* Unstable general condition,
* Sensitivity in the area where acupressure/placebo acupressure will be applied,
* Active COVID-19 infection,
* 15 July 2022 - 15 July 2023 who did not stay in the urology clinic,
* Patients with current psychiatric diagnosis will not be included in the study.
18 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Mersin University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Tugba CAM YANIK
PhD Research Assistant
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Gülay Altun Ugras, PhD
Role: STUDY_DIRECTOR
Mersin University
Mualla Yılmaz, PhD
Role: PRINCIPAL_INVESTIGATOR
Mersin University
Zeliha Yaman, PhD
Role: PRINCIPAL_INVESTIGATOR
Mersin University
Naciye Balbay, graduate
Role: PRINCIPAL_INVESTIGATOR
Mersin University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Turkey, Mersin University,
Mersin, Turkey/Mersin,Yenişehir, Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Mersin Univ
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.